© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Microbot Medical Inc. (MBOT) stock declined over -1.33%, trading at $1.48 on NASDAQ, down from the previous close of $1.50. The stock opened at $1.48, fluctuating between $1.47 and $1.57 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 1.50 | 1.57 | 1.47 | 1.48 | 1.51M |
| Aug 21, 2026 | 1.50 | 1.53 | 1.49 | 1.50 | 330.72K |
| Aug 20, 2026 | 1.56 | 1.57 | 1.48 | 1.49 | 613.15K |
| Aug 19, 2026 | 1.50 | 1.56 | 1.48 | 1.55 | 711.83K |
| Aug 18, 2026 | 1.50 | 1.51 | 1.44 | 1.47 | 1.36M |
| Aug 17, 2026 | 1.57 | 1.61 | 1.50 | 1.51 | 911.75K |
| Aug 14, 2026 | 1.68 | 1.69 | 1.45 | 1.55 | 2.72M |
| Aug 13, 2026 | 1.73 | 1.74 | 1.67 | 1.68 | 606.12K |
| Aug 12, 2026 | 1.72 | 1.76 | 1.71 | 1.74 | 420.74K |
| Aug 11, 2026 | 1.89 | 1.95 | 1.67 | 1.68 | 1.91M |
| Aug 10, 2026 | 1.88 | 1.96 | 1.88 | 1.94 | 619.45K |
| Aug 07, 2026 | 1.81 | 1.92 | 1.81 | 1.89 | 630.53K |
| Aug 06, 2026 | 1.85 | 1.88 | 1.80 | 1.80 | 401.74K |
| Aug 05, 2026 | 1.83 | 1.86 | 1.79 | 1.85 | 464.51K |
| Aug 04, 2026 | 1.80 | 1.84 | 1.78 | 1.82 | 644.67K |
| Aug 03, 2026 | 1.72 | 1.79 | 1.72 | 1.77 | 372.08K |
| Jul 31, 2026 | 1.75 | 1.76 | 1.68 | 1.72 | 309.6K |
| Jul 30, 2026 | 1.67 | 1.75 | 1.67 | 1.74 | 509.55K |
| Jul 29, 2026 | 1.70 | 1.72 | 1.65 | 1.67 | 534.42K |
| Jul 28, 2026 | 1.73 | 1.75 | 1.66 | 1.68 | 717.83K |
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
| Employees | 43 |
| Beta | 1.05 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |